Home / Drug shortages / Clindamycin Phosphate Injection

Clindamycin Phosphate Injection — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on 06/01/2026.

Shortage Details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0009-5095-06
Dosage Form
Injection
Presentation
Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06)
Initial Posting
06/01/2026
Revised Date

FDA data resources